Advertisement
Screener

Jazz Pharmaceuticals plc (JAZZ) Operating Leases, Future Minimum Payments, Due in Three Years

2.8 / 5 stars · 68/120 Roast Me

Jazz Pharmaceuticals plc Operating Leases, Future Minimum Payments, Due in Three Years

Jazz Pharmaceuticals plc (JAZZ) had Operating Leases, Future Minimum Payments, Due in Three Years of $5.77 million as of 2018-12-31, per its 10-K filed 2019-02-26.

Discontinued › Notes › Leases

us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-02-26

  • 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $5.77M.
  • 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $6.11M.
  • 2017-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $16.89M.
  • 2017-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $13.81M.
Period endOperating Leases, Future Minimum Payments, Due in Three Years
2018-12-31$5.77M
10-K · filed 2019-02-26
2017-12-31$6.11M
10-K · filed 2018-02-27
2017-09-30$16.89M
10-Q · filed 2017-11-07
2017-06-30$13.81M
10-Q · filed 2017-08-08
2017-03-31$10.82M
10-Q · filed 2017-05-09
2016-12-31$10.88M
10-K · filed 2017-02-28
2016-09-30$11.90M
10-Q · filed 2016-11-08
2016-06-30$8.61M
10-Q · filed 2016-08-09
2016-03-31$8.55M
10-Q · filed 2016-05-10
2015-12-31$8.31M
10-K · filed 2016-02-23
2015-09-30$12.56M
10-Q · filed 2015-11-09
2015-06-30$12.27M
10-Q · filed 2015-08-05
2015-03-31$7.14M
10-Q · filed 2015-05-07
2014-12-31$4.92M
10-K · filed 2015-02-24
2014-09-30$7.47M
10-Q · filed 2014-11-04
2014-06-30$7.29M
10-Q · filed 2014-08-05
2014-03-31$7.00M
10-Q · filed 2014-05-08
2013-12-31$6.42M
10-K · filed 2014-02-25
2013-09-30$8.83M
10-Q · filed 2013-11-05
2013-06-30$7.99M
10-Q · filed 2013-08-06
2013-03-31$5.32M
10-Q · filed 2013-05-07
2012-12-31$5.49M
10-K · filed 2013-02-26
2012-09-30$5.83M
10-Q · filed 2012-11-09
2012-06-30$5.71M
10-Q · filed 2012-08-07
2012-03-31$3.23M
10-Q · filed 2012-05-08
2011-12-31$366.00K
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Viatris Inc (VTRS)United States$20.008B-0.00
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28